Dr. Harish Peshwe


Consultant Gastroenterologist & Hepatologist


MBBS, MD, DNB ( General medicine), DNB ( Gastroenterology)


16 years

Past Experience In Years

  • Dr. Harish Peshwe after completing his MBBS is 1996 went for MD Medicine at Goa Medical College. He then further pursued his career to specialise in Gastroenterology. He is a Consultant Gastroenterologist and Hepatologist in Goa, with a huge experience
    in the medical profession. He is associated with several hospitals in Goa, including Grace Cardiac Hospital (Margao), Healthway Hospital (Panjim), Manipal Hospital (Dona Paula) and Galaxy Hospital (Mapusa). He specialises in Gastroenterology, Hepatology, Gastrointestinal Oncology and Clinical Nutrition.
  • Dr. Peshwe earlier worked with Global Hospitals in Hyderabad as a Consultant Gastroenterologist for two years up until December 2007. Prior to that he was at Apollo Hospital in Hyderabad, in the same capacity. He was actively involved in therapeutic endoscopy procedures including ERCP for stone extraction, stenting for biliary malignancies, stone disease and pancreatic endotherapy, GI bleeds and other routine diagnostic procedures. He gained experience in double balloon enteroscopy for small bowel bleeds, and narrow band imaging and chromoendoscopy for detection of early neoplastic lesions in the GI tract followed by EMR if required.
  • Dr. Harish Peshwe was formally trained in Gastroenterology at the Tata Memorial Hospital in Mumbai, where he was Senior Resident/Registrar and later Specialist Registrar in the Department of Digestive Diseases and Clinical Nutrition (Jan 2002 to Aug (2005), culminating in the award of the DNB (Medical Gastroenterology) title. This department at Tata Memorial is actively involved in gastrointestinal oncology


  • Article
    Lamivudine for control of acute HBV infection during cancer chemotherapy. Proceedings of the 1st Asian American International Medical Conference. 2003; 1:33. [Abstract]
    Role of EUS in predicting curative resection in esophageal cancer preoperatively. Indian J Gastroenterol. 2003; 22 (Suppl-1): A124. [Abstract]
    Metastatic GIST: New hope from targeted chemotherapy. Indian J Gastroenterol. 2003; 22 (Suppl-
    1): A17. [Abstract] PET_and_PETCT_in_the_clinical_management_of_gastrointestinal_stromal_tumor

  • The management of gastrointestinal stromal tumors (GISTs) has been revolutionized in recent years by two major developments: the introduction of imatinib mesylate as a targeted therapeutic agent and the dramatic change in the tumor metabolic activity
    following successful therapy making in fluorodeoxyglucose (FDG)-PET as the modality of choice for m…


We report diffuse intense FDG uptake in the bone marrow in a patient who had undergone surgery for gastric antral gastrointestinal stromal tumor unrelated to the primary malignancy. The FDG-PET demonstrated diffusely enhanced uptake of the radiotracer in the vertebrae, pelvis, and the proximal long bones. The history revealed coexistent polycythemi…

Awards and Recognition

  • Gold Medal for standing first in National Board of Examinations for DNB Medical Gastroenterology. 2005.
  • Best Paper (Oral) Award at Indian Society of Gastroenterology conference. 2003
  • Poster paper Award Indian Society of Gastroenterology conference, Chennai, 2003
  • Young Clinician program award, 1 st Asian American International Medical Conference , Goa 2003
  • GMC college prize for standing first in MBBS
  • Gold Medal of the XXXIV Annual Gastroenterology conference 1995
  • Gold Medal for medicine 1995, Goa University
  • Gold Medal for medicine 1995, Goa medical college
  • Gold Medal for medicine 1995, Pfizer trophy
  • Gold Medal for medicine 1995, Individual award


  • Member of Indian Society of Gastroenterology